glp-1 price drop Study: US obesity rates are dropping as use increases Novo Nordisk Announces Significant Price

Exclusive-Cigna drops coverage of GLP-1 obesity drugs for its own employees By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan effective July 1, according to materials viewed by Reuters on Tuesday

Can you afford long-term treatment

The trial aims to enroll 700 participants, and will run 78 weeks (estimated readout 1H 2025)

Then the body starts feeling shaky, nauseous, weak, foggy, or dizzy

membership-based telehealth platform offering GLP-1 weight loss treatment, urgent and primary care, and lab testing